Select Medical Holdings CORP Form 4 insider transactions

Select Medical Holdings Corp. Executive Vice President Michael E. Tarvin reported the surrender of 19,640 shares of common stock to cover tax obligations related to restricted stock vesting.

Martin F. Jackson, Executive Vice President of Select Medical Holdings Corp, disposed of 29,460 common shares to cover tax obligations from restricted stock vesting.

Select Medical Holdings Corp. CEO David S. Chernow disposed of 49,100 shares of common stock to cover tax obligations related to restricted stock vesting.

Select Medical Holdings Corp's Chief Information Officer, Brian R. Rusignuolo, disposed of 14,680 common shares to cover tax withholding obligations related to restricted stock vesting.

Select Medical Holdings Corp. Director Daniel Thomas was granted 14,035 shares of restricted common stock, vesting on July 29, 2026.

Select Medical Holdings Corp. Executive Vice President John A. Saich was granted 100,000 shares of restricted common stock, vesting in 2028.

Select Medical Holdings Corporation director Katherine R. Davisson was granted 14,035 shares of restricted common stock, vesting on July 29, 2026.

Select Medical Holdings Corp. Director James S. Ely III was granted 14,035 shares of restricted common stock, enhancing his beneficial ownership to 161,674 shares.

Select Medical Holdings Corp. director Parvinderjit S. Khanuja was granted 14,035 shares of restricted common stock, vesting on July 29, 2026.

Robert A. Ortenzio, Executive Chairman of Select Medical Holdings Corp, was granted 250,000 shares of restricted common stock, vesting over three years.

Select Medical Holdings Corp. Director William H. Frist acquired 15,298 shares of common stock through restricted stock grants on July 29, 2025, increasing his beneficial ownership to 302,797 shares.

Michael E. Tarvin, Executive Vice President of Select Medical Holdings Corp, was granted 100,000 shares of restricted common stock, vesting over three years.

Select Medical Holdings Corp. CEO David S. Chernow was granted 250,000 shares of restricted common stock, vesting over three years, as reported in a recent SEC Form 4 filing.

Select Medical Holdings Corp's Executive Vice President, Martin F. Jackson, was granted 150,000 shares of restricted common stock, aligning executive interests with shareholder value.

Select Medical Holdings Corp. Co-President Thomas P. Mullin received a grant of 100,000 restricted shares, aligning executive incentives with long-term company performance.

Select Medical Holdings Corp.'s Chief Financial Officer, Michael F. Malatesta, was granted 75,000 shares of restricted common stock, vesting in 2028.

Select Medical Holdings Corp. Director Marilyn B. Tavenner is set to receive a grant of 14,035 restricted common shares, vesting in July 2026.

Select Medical Holdings Corp.'s Chief Information Officer, Brian R. Rusignuolo, was granted 75,000 shares of restricted common stock, vesting in 2028.

Select Medical Holdings Corp. Director and 10% owner Thomas Scully was granted 14,035 shares of common stock, vesting on July 29, 2026.

Russell L. Carson, a Director and 10% Owner of Select Medical Holdings Corp., reported gifting 500,000 shares of common stock and receiving a grant of 14,035 restricted shares.

Director Parvinderjit S. Khanuja of Select Medical Holdings Corp. recently purchased 21,000 shares of common stock at an average price of $15.02.

Robert G. Breighner JR., Vice President of Compliance at Select Medical Holdings Corp, surrendered shares to cover tax obligations related to vesting restricted stock.

Michael Tarvin, Executive Vice President of Select Medical Holdings, reports the surrender of shares to cover tax obligations related to vesting restricted stock.

CEO David Chernow of Select Medical Holdings Corp. reports disposition of shares to cover tax obligations related to vesting restricted stock.

Director William H. Frist acquired 978 shares of Select Medical Holdings Corp. common stock on April 29, 2025, in lieu of a quarterly retainer.

Robert G. Breighner JR, Vice President of Compliance at Select Medical Holdings Corp, acquired 7,000 shares of restricted stock on April 29, 2025, which will vest on April 29, 2029.

Select Medical Holdings CEO David Chernow sold 225,000 shares of common stock at $18 per share on April 28, 2025, according to a Form 4 filing.

Director William H. Frist acquired 987 shares of Select Medical Holdings Corp. common stock on February 12, 2025, in lieu of a quarterly retainer.

Robert G. Breighner Jr., Vice President of Compliance at Select Medical Holdings, sold 4,989 shares of common stock on December 4, 2024.

Robert A. Ortenzio, Executive Chairman of Select Medical Holdings, sold 3,804,805 shares of common stock at a price of $19.55 per share on November 26, 2024.